2019 to 2023
Interreg Atlantic EAPA_791/2018-NEUROATLANTIC
Total budget: 1.768.663,92€

neuroATLANTIC aims to bring together the remarkable scientific and technological capabilities found in the Atlantic Area in the field of neurological diseases (eg Alzheimer’s disease, stroke, etc.).

This project will act on clinical, preclinical and capitalization aspects, accelerating the adoption of new innovations that will revolutionize the way neurological diseases are managed within the area.

It will also focus on creating a transnational platform to develop new therapeutic agents for the treatment and early diagnosis of these devastating and prevalent diseases.

CSG's role

CSG is responsible for capitalization (WP leader) and communication.